tiprankstipranks
Trending News
More News >
Vericel Corp (VCEL)
NASDAQ:VCEL
US Market
Advertisement

Vericel (VCEL) Earnings Dates, Call Summary & Reports

Compare
629 Followers

Earnings Data

Report Date
Nov 06, 2025
TBA (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
>-0.01
Last Year’s EPS
-0.02
Same Quarter Last Year
Based on 6 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 31, 2025|
% Change Since: 5.98%|
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance with significant revenue growth across key segments and robust profitability metrics. Despite a few challenges such as Epicel cancellations and adjusted guidance for Burn Care, the overall business outlook remains positive with promising growth indicators, especially in the MACI segment.
Company Guidance -
Q3 2025
During the Vericel Corporation's Second Quarter 2025 Earnings Call, the company reported a strong financial performance with total revenue increasing by 20% from the previous year. The gross margin expanded by over 400 basis points to 74%, and adjusted EBITDA rose by 112% to over $13 million. The MACI segment achieved record second quarter revenue of nearly $54 million, marking a 21% increase over the prior year and a 15% sequential growth from the previous quarter. Additionally, biopsies and implants showed significant growth, with the number of MACI Arthro trained surgeons reaching approximately 600 by the end of July. The Burn Care segment also showed improvement with Epicel revenue rising by 11% and biopsies increasing by nearly 40% compared to the previous year. The company's cash and investments totaled approximately $164 million with no debt, and it maintained a guidance for full-year MACI revenue growth in the low 20% range.
Significant Revenue Growth
Total revenue increased by 20% in the quarter, driven by strong performance across MACI and Burn Care segments.
MACI Record Revenue
MACI generated record second-quarter revenue of nearly $54 million, representing 21% growth versus the prior year and 15% sequential growth versus the prior quarter.
MACI Arthro Surge
MACI Arthro surgeon training exceeded expectations, with approximately 600 surgeons trained, contributing to biopsy and implant growth.
Burn Care Performance Rebound
Epicel biopsies increased nearly 40% over the previous year, with the highest monthly biopsies on record in June.
NexoBrid Growth
NexoBrid saw a strong close to the quarter with the highest number of ordering centers and hospital units ordered since launch, with July orders exceeding June's record numbers.
Adjusted EBITDA Increase
Adjusted EBITDA increased by 112% to over $13 million, indicating strong profitability growth.
Strong Cash Position
The company ended the second quarter with approximately $164 million in cash and investments and no debt.

Vericel (VCEL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

VCEL Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Nov 06, 2025
2025 (Q3)
>-0.01 / -
-0.02
Jul 31, 2025
2025 (Q2)
-0.03 / -0.01
-0.190.00% (+0.09)
May 08, 2025
2025 (Q1)
-0.12 / -0.23
-0.08-187.50% (-0.15)
Feb 27, 2025
2024 (Q4)
0.32 / 0.38
0.2646.15% (+0.12)
Nov 07, 2024
2024 (Q3)
-0.05 / -0.02
-0.0875.00% (+0.06)
Aug 01, 2024
2024 (Q2)
-0.09 / -0.10
-0.119.09% (<+0.01)
May 08, 2024
2024 (Q1)
-0.11 / -0.08
-0.1650.00% (+0.08)
Feb 29, 2024
2023 (Q4)
0.17 / 0.26
0.12116.67% (+0.14)
Nov 08, 2023
2023 (Q3)
-0.12 / -0.08
-0.1442.86% (+0.06)
Aug 02, 2023
2023 (Q2)
-0.15 / -0.11
-0.1942.11% (+0.08)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

VCEL Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 31, 2025
$40.66$34.94-14.07%
May 08, 2025
$40.47$41.87+3.46%
Feb 27, 2025
$52.85$49.62-6.11%
Nov 07, 2024
$48.04$50.03+4.14%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Vericel Corp (VCEL) report earnings?
Vericel Corp (VCEL) is schdueled to report earning on Nov 06, 2025, TBA (Confirmed).
    What is Vericel Corp (VCEL) earnings time?
    Vericel Corp (VCEL) earnings time is at Nov 06, 2025, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is VCEL EPS forecast?
          VCEL EPS forecast for the fiscal quarter 2025 (Q3) is >-0.01.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis